Internal Medicine, Endocrinology, Diabetes, & Metabolism · North Bergen, NJ
NPI
1801020524
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
6045 Kennedy Blvd, Suite B
North Bergen, NJ, 07047
Phone (201) 453-0322
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
3,190 services
Medicare patients, 2024
236
Average age 74
Drug cost, 2024
$3.7M
9,721 prescriptions
Company payments, 2025
$1,149
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sonal Pathak was code J0897 (injection, denosumab, 1 mg), 1,622 times for 19 patients. In total Sonal Pathak billed 3,190 services in 14 codes, and Medicare paid $61K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-03-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,622 | 19 | $0.00 | $0.28 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 319 | 192 | $13.80 | $4,403 |
| 99214 Office E&M - Established | Office | 219 | 138 | $107.90 | $24K |
| 99443 Telephone Services | Office | 100 | 73 | $81.99 | $8,199 |
| 99215 Office E&M - Established | Office | 66 | 48 | $153.41 | $10K |
| 99442 Telephone Services | Office | 61 | 48 | $63.73 | $3,888 |
| 95251 Test - Miscellaneous | Office | 46 | 28 | $27.62 | $1,271 |
| 96372 Injection Administration | Office | 46 | 19 | $12.60 | $580 |
| 95250 Test - Miscellaneous | Office | 26 | 16 | $124.87 | $3,247 |
| 99205 Office E&M - New | Office | 16 | 16 | $178.89 | $2,862 |
| 99204 Office E&M - New | Office | 16 | 16 | $128.17 | $2,051 |
By year: 2022 $54K for 2,807 services; 2023 $52K for 2,795 services; 2024 $61K for 3,190 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sonal Pathak prescribed most often to Medicare patients was Levothyroxine Sodium, with 974 prescriptions and refills. In total Sonal Pathak wrote 9,721 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 974 | 2,481 | 269 | $8,869 |
| Metformin Hcl Generic | 824 | 2,207 | 239 | $5,390 |
| Repaglinide Generic | 553 | 1,393 | 157 | $19K |
| Ozempic Semaglutide | 521 | 746 | 87 | $694K |
| Jardiance Empagliflozin | 480 | 988 | 117 | $569K |
| Rosuvastatin Calcium Generic | 382 | 1,031 | 119 | $6,364 |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 266 | 435 | 57 | $7,518 |
| Synthroid Levothyroxine Sodium | 262 | 569 | 57 | $25K |
| Januvia Sitagliptin Phosphate | 259 | 473 | 55 | $251K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 238 | 458 | 85 | $18K |
| Atorvastatin Calcium Generic | 234 | 653 | 76 | $2,485 |
| Alendronate Sodium Generic | 219 | 531 | 67 | $1,867 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 218 | 503 | 54 | $21K |
| Methimazole Generic | 190 | 495 | 49 | $1,779 |
| Tresiba Flextouch U-100 Insulin Degludec | 167 | 399 | 45 | $86K |
Brand drugs: 4,298 claims; generic drugs: 4,022 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sonal Pathak $1,149 ($1,149 in general payments such as food, travel and fees) from 15 companies. The largest payer was Amgen Inc. with $471.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 8 | $471 |
| Xeris Pharmaceuticals, Inc. | 5 | $186 |
| Medtronic, Inc. MDT | 1 | $76.88 |
| Lilly USA, LLC LLY | 3 | $61.08 |
| Kyowa Kirin, Inc. 4151.T | 3 | $57.01 |
| Corcept Therapeutics CORT | 3 | $56.18 |
| CeQur Corporation | 1 | $49.13 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Ascensia Diabetes Care Us Inc. | 1 | $32.12 |
| Beta Bionics, Inc. BBNX | 1 | $27.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.